Neudle.com: drug interactions

Differential
(Click to cross reference)

abdominal protrusion

acetaminophen

acetylcholine

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acromegaly

acupuncture

acyclovir

advances in neurology

adverse drug reaction

alpha methyldopa hydrazine

alpha-fetoprotein

alternative medicine

Alzheimer's disease

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticoagulant, discontinuation

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, mechanism of action of

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

artificial intelligence

aspartate aminotransferase

atrioventricular block

atypical

autonomic dysfunction

beta adrenergic blocker

calcium antagonist, side effects of

carbamazepine

carbamazepine, controlled release

carbamazepine, toxicity

carbidopa

cardiovascular disease

carnitine deficiency

case studies

CAT scan, angiography

CAT scan, emission

catechol-o-methyltransferase inhibitor

CD4 counts

cerebellar hemorrhage

cerebral embolism, cardiac origin

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, prevention of

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest pain

children

chiropractic manipulation

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

Coombs test, positive

coronary artery disease

coronary artery spasm

creatine phosphokinase(CPK)elevated

dementia, treatment of

deprenyl

depression

desipramine

dexamethasone suppression test

dilantin, factors influencing metabolism of

dilantin, saliva level

dilantin, serum level

drug induced neurologic disorders

drug interactions

drug overdose

drug overdose, management of

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dyspepsia

dyspnea

dystonia

dystonia, treatment of

Echinacea

efficacy

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

electromyogram

embolism, silent

emergencies, neurologic

epidemiology of neurology

epilepsy referral centers

evidence-based research

gamma amino butyric acid-mimetic drug

gangrene

gastrointestinal bleeding

gemfibrozil

gender

Generative Pretrained Transformer 4

generic drugs

genetic neurologic disorders

genetic testing

ginkgo biloba

ginseng

globus pallidus, stimulation

glucose tolerance test, abnormal

groaning

hallucination

hallucination, visual

haloperidol

headache

headache, treatment of

heart block

heart valve, prosthetic

histamine-2 receptor blockers

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hypotension, systemic

iatrogenic neurologic disorders

imipramine

immunosuppression

inappropriate antidiuretic(A.D.H.)hormone

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, plasma concentration

L-dopa, potentiators of

Lennox-Gastaut syndrome

Lewy body disease, diffuse

liver function enzymes

locus ceruleus, lesion of

memory, impairment of

mental status, abnormal

microhemorrhage, intracerebral

migraine

migraine, prophylaxis

migraine, treatment of

misdiagnosis

mitochondrial disease

modafinil

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

multiple sclerosis

multiple sclerosis, treatment of

myasthenia gravis, diagnosis

myasthenia gravis, misdiagnosis of

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myocardial infarction

myocardial infarction, acute

myopathy, drug-induced

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologist

neuromuscular blockade

neuronal degeneration

nigrostriatal pathway

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

number needed to treat

olanzapine

old age, neurology of

oral contraceptives, choreiform movements with

organ transplantation

orthostatic hypotension

pain, management of chronic

parietal lobe, lesion of

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, fluctuations in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

patient information and support

pergolide

peripheral pulse, absent

phenothiazine, dyskinesia associated with

phobias

platelet inhibiting drugs

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

procyclidine

prognosis

progressive supranuclear palsy

propoxyphene

protease inhibitor, HIV-1

proton pump inhibitors

psychiatric disorder

psychiatric problems in neurologic disorders

pupil, dilated, bilateral

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respirator

respiratory dyskinesias

respiratory failure

respiratory paralysis, pharmacologic

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, neonatal

seizure, non-treatment of

seizure, paradoxical

seizure, pregnancy

seizure, prognosis in adults

seizure, psychomotor-temporal lobe

seizure, remission

seizure, surgical treatment of

seizure, systemic disease causing

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, women

selective serotonin reuptake inhibitors

serum alanine aminotransferase

shivering

simvastatin

sinemet

single photon emission computed tomography

sinus arrest

skin, discoloration

sleep pathology and physiology

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

spasticity

spasticity, treatment of

spina bifida

spinal cord, injury of

St. John's wort

start hesitation

statin therapy

statin therapy, discontinuation

statin therapy, dose

status epilepticus

status epilepticus, nonconvulsive

stimulation, deep brain

stress management

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

temporal lobe, status

teratogenesis

teratogenic drugs

tetrahydroaminoacridine

thrombotic thrombocytopenia purpura

transient ischemic attack

trazodone

treatment of neurologic disorder

tremor

tremor, thalamic stimulation for suppression of

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, treatment of

triglycerides

triptans

ultrasonography

ultrasonography, head, fetus-neonate

uremia

urine, dark

vagus nerve stimulation

venous thrombosis, non-cerebral

voice, abnormality of

Showing articles 150 to 200 of 6670 << Previous Next >>

Heart Block Secondary to Erythromycin-Induced Carbamazepine Toxicity
Pediatrics 80:951-953, Macnab,A.J.,et al, 1987

Clinical Valproate Toxicity Induced by Acetylsalicylic Acid
Neurol 37:1392-1394, Goulden,K.J.,et al, 1987

Initiation of Levodopa Therapy in Parkinsonisn Patients Should be Delayed Until the Advanced Stages of the Disease
Arch Neurol 43:402-407, Melamen,E., 1986

Carbamazepine-Erythromycin Interaction, Case Studies & Clinical Significance
JAMA 255:1165-1167, Wroblewski,B.A.,et al, 1986

Verapamil Potentiates Carbamazephine Neurotoxicity:A Clinically Important Inhibitory Interaction
Lancet 1:700-703, Macphee,G.A.,et al, 1986

Carbamazepine Neurotoxicity Precipitated by Dilitiazem
BMJ 292:1170-1171, Brodie,M.J.,et al, 1986

Dystonia-Parkinson Syndrome:Differential Effects of Levodopa and Dopamine Agonists
Clin Neuropharmacol 9:298-302, Klawans,H.L.&Paleologos,N., 1986

A Neuroleptic Malignantlike Syndrome Due to Levodopa Therapy Withdrawal
JAMA 254:2792-2795, Friedman,J.H.,et al, 1985

Development of Malignant Melanoma after Levodopa Therapy for Parkinson's Disease, Report of Case & Review
Am J Med 79:119-121, Kochar,A.S., 1985

Levodopa & Melanoma:Three Cases & Review of Literature
JNNP 48:585-588, Rampen,F.H.J., 1985

Carbamazepine Toxicity Induced by Concurrent Erythromycin Therapy
Arch Neurol 42:187-188, Carranco,E.,et al, 1985

Hyperthermia after Discontinuance of Levodopa & Bromocriptine Therapy:Impaired Dopamine Receptors a Possible Cause
Neurol 35:258-261, Figa-Talamanca,L.,et al, 1985

L-Dopa-Induced Respiratory Disturbance in Parkinson's Disease Suppressed by Tiapride
Neurol 35:235-237, DeKeyser,J.,et al, 1985

Fatal Hyperpyrexia After Withdrawal of Levodopa
Neurol 34:249-251, Sechi,G.P.,et al, 1984

The Measurement of Anticonvulsant Agent Levels
Ann Int Med 100:854-858, Troupin,A.S., 1984

Chronic Low-Dose Levodopa Therapy in Parkinson's Disease:An Argument for Delaying Levodopa Therapy
Neurol 34:991-996, Rajput,A.H.,et al, 1984

Phenytoin Intoxication During Treatment with Parenteral Miconazole
BMJ 287:1760, Rolan,P.E.,et al, 1983

Effect of Carbamazepine on Coumadin Metabolism
Ann Neurol 13:691-692, Massey,E.W., 1983

Interaction Between Phenobarbital & Thoridazine
Neurol 33:1631-1632, Gay,P.E.,et al, 1983

Benzodiazepines
NEJM 309:354-358, 410-4161983., Greenblatt,D.J.,et al, 1983

Ethosuximide Intoxication Caused by Interaction with Isoniazid
Neurol 33:1227-1228, vanWieringen,A.,et al, 1983

Methsuximide for Complex Partial Seizures:Efficacy, Toxicity, Clinical Pharmacology, & Drug Interactions
Neurol 33:414-418, Browne,T.R.,et al, 1983

Meige's Syndrome During Long-term Dopaminergic Therapy in Parkinson's Disease
Arch Neurol 39:451-452, Weiner,W.J.,et al, 1982

Drug Interaction with Coumarin Derivative Anticoagulants
BMJ 285:274-275, Sharp,A.A., 1982

Drug-induced Asterixis in Parkinson Disease
Neurol 32:553-555, Glantz,R.,et al, 1982

Phenytoin-Theophylline Interaction
NEJM 307:1189-1190, Marquis,J-F.,et al, 1982

Isoniazid-Induced Carbamazepine Toxicity & Vice Versa, A Double Drug Interaction
NEJM 307:1325-1327, Wright,J.M.,et al, 1982

Cimetidine Interaction with Phenytoin
BMJ 282:1512, Hetzel,D.J.,et al, 1981

Phenytoin-Induced Methadone Withdrawal
Ann Int Med 94:349-351, Tong,T.G.,et al, 1981

Sinemet & the Treatment of Parkinsonism
Ann Int Med 94:364-370, Boshes,B., 1981

Complications of Chronic Levodopa Therapy; Long-term Efficacy of Drug Holiday
Neurol 31:473-476, Koller,W.C.,et al, 1981

Interaction Between Estrogen & Dilantin In A Menopausal Woman
NEJM 304:788-789, Notelovitz,M.,et al, 1981

Delayed Clearance of Diazepam Due to Cimetidine
NEJM 302:1012-1014, Klotz,U.,et al, 1980

Interaction Between Carbamazepine & Warfarin
BMJ 280:1415-1416, Ross,J.R.Y.,et al, 1980

Valproic Acid & Ethosuximide Interaction
Ann Neurol 7:583-584, Mattson,R.H.,et al, 1980

Phenothiazine-Induced Phenytoin Intoxication
Ann Int Med 93:56-57, Vincent,F.M., 1980

Analysis of the Clinical Problems in Parkinsonism & the Complications of Long-term Levodopa Therapy
Neurol 29:1253-1260, Lesser,R.P.,et al, 1979

Dementia in Parkinson Disease
Ann Neurol 6:355-359, Lieberman,A.,et al, 1979

Interaction Between Clonazepam & Sodium Valproate
NEJM 300:678-679, Watson,W.A., 1979

Parkinsonism With`On-Off'Phenomena-Intravenous Treatment With Levodopa After Major Abdominal Surgery
Arch Neurol 36:32-34, Rosin,A.J.,et al, 1979

Early-Morning Dystonia-A Late Side Effect of Long-Term Levodopa Therapy
Arch Neurol 36:308-310, Melamed,E., 1979

The L-Dopa On-Off Effect in Parkinson Disease:Treat. by Trans. Drug Withdrawal & Dopamine Receptor Resens
Ann Neurol 4:573-575, Direnfeld,L.,et al, 1978

Respiratory Dyskinesias:Extrapyramidal Dysfunction & Dyspnea
Ann Int Med 88:327, Weiner,W.J.,et al, 1978

Considerations in the Management of Parkinsonism
Neurol 28:5, Fahn,S.,et al, 1978

Onset & End-of-dose Levodopa-induced Dyskinesias
Arch Neurol 35:261, Lhermitte,F.,et al, 1978

Drug Therapy of Parkinsonism
NEJM 295:814, Bianchine,J.R., 1976

Drugs that Reduce Efficacy of Levodopa
(Letter) , NEJM 295:153876., Hausner,R., 1976

Interaction of Quinidine with Anticonvulsant Drugs
NEJM 294:699, Data,J.L.,et al, 1976

Levodopa-Induced Myoclonus
Arch Neurol 32:331-334, Klawans,H.L., 1975

Prolonged Levodopa Therapy
BMJ 383, Feb 1973., , 1973

Showing articles 150 to 200 of 6670 << Previous Next >>